The Efficacy and Safety of Roxadustat for the Treatment of Posttransplantation Anemia: A Randomized Study

The Efficacy and Safety of Roxadustat for the Treatment of Posttransplantation Anemia: A Randomized Study

Introduction: Roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, can stimulate erythropoiesis. Our objective was to evaluate the efficacy and safety of roxadustat for the treatment of posttransplantation anemia (PTA). Methods: A total of 150 adult renal transplant re...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiwei Kong, Xiaoying Wu, Zhuowei Shen, Meifang Wang, Xinyu Liu, Xiaoli Lin, Yingyin Qiu, Hong Jiang, Jianghua Chen, Yan Lou, Hongfeng Huang
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Kidney International Reports
Subjects:
chronic kidney disease
HIF signaling
randomized controlled study
renal anemia
renal transplantation
roxadustat
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924016449
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items